Royal Fund Management 13F: New $1.6M Stake in NOC
Key Points
- Royal Fund Management initiated a new holding in Northrop Grumman Corporation NOC by purchasing 3,209 shares valued at $1,551,487 as of its October 22, 2026 filing.
- Other major institutional investors adjusted their holdings during the period, including Midwest Trust which reduced its stake by 8,536 shares.
- Northrop Grumman Corporation trades around $552.32 with a consensus buy recommendation and a mean price target of $630.00 across 24 analysts.
Get Northrop Grumman text alerts
We text you when insiders, Congress, analysts or big funds move on $NOC.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Northrop Grumman Corporation alert may contain errors. Disclosures
Royal Fund Management opened a new position in Northrop Grumman Corporation NOC, acquiring 3,209 shares valued at about $1.55 million. The investment was revealed in a Form 13F regulatory filing with the U.S. Securities and Exchange Commission on October 22, 2026.
What Changed in Royal Fund Management's Northrop Grumman Position
The fund initiated a brand-new stake in the aerospace and defense company during the period, moving from zero shares up to 3,209 shares. Based on the filing date, the reported value of the holding stood at $1,551,487.
Other Institutional Activity in Northrop Grumman
Other large money managers made notable adjustments to their Northrop Grumman portfolios around the same reporting cycle. Midwest Trust reduced its holdings by 8,536 shares, ending the period with 67,923 shares worth about $32.84 million. Capital International Investors trimmed its stake by 1,244,057 shares down to 5,852,674 shares valued at roughly $3.23 billion. Meanwhile, Franklin Resources, Inc. grew its holdings by 95,750 shares, raising its total to 3,374,876 shares worth about $1.86 billion.
Northrop Grumman Corporation Stock Up 3.4%
Northrop Grumman Corporation shares recently traded around $552.32, sitting about 5.5% above their 50-day moving average of $523.35. On the filing date of October 22, 2026, the stock closed at $552.35. The company carries a market capitalization of roughly $76.62 billion.
Recent Earnings
Northrop Grumman Corporation generated trailing twelve month revenue of $42.89 billion alongside earnings of $31.68 per share. The defense contractor posted a net profit margin of 10.5% and a return on equity of 27.0%. Its next earnings report is scheduled for release on January 26, 2027.
Dividend
The firm pays an annual dividend rate of $9.88 per share, which translates to a dividend yield of 1.93%. The payout ratio currently sits at 29.9%.
Insider Buying and Selling at Northrop Grumman Corporation
Corporate insiders were active in company shares across the months leading up to the filing. Director Mark A. Welsh III disposed of 95 shares on May 4, 2026, and another 95 shares on August 3, 2026. On the buying side, insider Arvind Krishna purchased 71 shares on June 30, 2026, at an average price of $509.31 for a total value of $36,161.01. Fellow insider Brown Marianne Catherine bought 91 shares on the same date at $509.31 per share for a total value of $46,347.21.
Analysts Set New Price Targets
Wall Street firms updated their outlooks around the time of the filing. UBS maintained its Buy rating on October 21, 2026, while lifting its price target from $694.00 to $698.00. BNP Paribas kept an Outperform rating on October 21, 2026, and raised its target from $540.00 to $600.00. Morgan Stanley maintained an Overweight rating on October 21, 2026, boosting its target from $745.00 to $765.00. Guggenheim maintained a Buy rating on October 21, 2026, moving its target from $612.00 to $640.00. Finally, Barclays kept an Underweight rating on October 22, 2026, while nudging its target from $419.00 to $430.00. Across the broader analyst community, the stock holds a consensus buy recommendation and a mean price target of $630.00 across 24 analyst opinions.
About Northrop Grumman
Northrop Grumman Corporation operates as an aerospace and defense technology company, supplying advanced systems and solutions for military and commercial customers worldwide. The company is structured around four primary segments covering aeronautics, defense systems, mission systems, and space technology, supporting major national security and exploration programs.
Bottom Line
Institutional interest in major defense contractors remains active as portfolio managers adjust allocations. Observers will look toward the company's next earnings release on January 26, 2027, for further details on operational performance and revenue trends.
Source: Royal Fund Management's 13F filing on $NOC (Oct 22, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts